How are new medicines approved by EMA?

13th September 2018

Find out what it takes to develop a medicine and to get it authorised

All medicines must be authorised before they can be marketed and made available to patients in the European Union (EU).

When all the relevant information has been collected from laboratory tests and clinical trials, the European Medicine’s Agency’s (EMA) scientific committees conduct a comprehensive scientific evaluation of the data and provide independent recommendations on medicines for human and veterinary use.

If the benefits of the medicine are greater than its risks, EMA gives the green light and recommends to the European Commission that the medicine can be marketed across the EU, as well as in the European Economic Area.

Read more

  • Share:

Sign Up to receive our newsletter

© Medilink WM. All rights reserved.

Created by Gritt and Co